CVS Health Co. (NYSE:CVS) Receives $74.74 Consensus Target Price from Brokerages

Shares of CVS Health Co. (NYSE:CVS - Get Free Report) have received an average recommendation of "Moderate Buy" from the twenty-one analysts that are presently covering the stock, Marketbeat reports. Eight analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $75.26.

A number of research firms have commented on CVS. Cantor Fitzgerald reiterated a "neutral" rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Barclays upgraded CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $63.00 to $82.00 in a research report on Thursday. Royal Bank of Canada restated an "outperform" rating and set a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft cut their target price on CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a research report on Friday, August 9th. Finally, Wells Fargo & Company upped their target price on CVS Health from $60.00 to $61.00 and gave the company an "equal weight" rating in a research report on Monday, August 12th.

CVS Health Trading Down 0.3 %

Shares of NYSE CVS traded down $0.22 during trading on Friday, reaching $66.63. The company had a trading volume of 12,907,688 shares, compared to its average volume of 11,037,586. The company's fifty day moving average price is $58.97 and its 200-day moving average price is $61.24. CVS Health has a 12 month low of $52.77 and a 12 month high of $83.25. The stock has a market cap of $83.65 billion, a P/E ratio of 11.71, a PEG ratio of 0.93 and a beta of 0.54. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts' consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the previous year, the company posted $2.21 EPS. The business's revenue was up 2.6% on a year-over-year basis. As a group, research analysts expect that CVS Health will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.99%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health's dividend payout ratio (DPR) is presently 46.75%.

Institutional Trading of CVS Health

Several institutional investors and hedge funds have recently modified their holdings of CVS. Wedmont Private Capital increased its position in shares of CVS Health by 0.8% during the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator's stock valued at $1,410,000 after acquiring an additional 146 shares during the last quarter. Moody National Bank Trust Division increased its position in shares of CVS Health by 0.7% during the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator's stock valued at $1,776,000 after acquiring an additional 150 shares during the last quarter. Garland Capital Management Inc. increased its position in shares of CVS Health by 0.3% during the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock valued at $3,591,000 after acquiring an additional 160 shares during the last quarter. Sound Income Strategies LLC increased its position in shares of CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after acquiring an additional 162 shares during the last quarter. Finally, Silverlake Wealth Management LLC increased its position in shares of CVS Health by 1.6% during the first quarter. Silverlake Wealth Management LLC now owns 11,203 shares of the pharmacy operator's stock valued at $894,000 after acquiring an additional 173 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.